GABA(A) alpha-1 subunit mediated desynchronization of elevated low frequency oscillations alleviates specific dysfunction in stroke – A case report

OBJECTIVE The paradoxical effects of the hypnotic imidazopyridine zolpidem, widely reported in persistent vegetative state, have been replicated recently in brain-injured and cognitively impaired patients. However, the neuronal mechanisms underlying these benefits are yet to be demonstrated. We implemented contemporary neuroimaging methods to investigate sensorimotor and cognitive improvements, observed in stroke patient JP following zolpidem administration. METHODS We used Magnetic-Resonance-Imaging (MRI) and Magnetic-Resonance-Spectroscopy (MRS) to anatomically and chemically characterize stroke damage. Single-photon-emission-computed-tomography (SPECT) and magnetoencephalography (MEG) were used to identify changes in cerebrovascular perfusion and neuronal network activity in response to sub-sedative doses of zolpidem, zopiclone and placebo. Cognitive improvements were measured using the WAIS-III and auditory-verbal tasks. RESULTS MRI and MRS revealed a lesion with complete loss of neuronal viability in the left temporal-parietal region; whilst SPECT indicated improved perfusion in the affected hemisphere following zolpidem. MEG demonstrated high-amplitude theta (4-10 Hz) and beta (15-30 Hz) oscillations within the peri-infarct region, which reduced in power coincident with zolpidem uptake and improvements in cognitive and motor function. CONCLUSIONS In JP, functional deficits and pathological oscillations appear coincidentally reduced following administration of low-dose zolpidem. SIGNIFICANCE GABA(A) alpha-1 sensitive desynchronisation of pathological oscillations may represent a biomarker and potential therapeutic target in brain injury.

[1]  A. Oliviero,et al.  Dopamine Dependency of Oscillations between Subthalamic Nucleus and Pallidum in Parkinson's Disease , 2001, The Journal of Neuroscience.

[2]  N. Logothetis,et al.  Neurophysiological investigation of the basis of the fMRI signal , 2001, Nature.

[3]  Norihiko Fujita,et al.  Movement-Related Desynchronization of the Cerebral Cortex Studied with Spatially Filtered Magnetoencephalography , 2000, NeuroImage.

[4]  G. Barnes,et al.  Neuronal network pharmacodynamics of GABAergic modulation in the human cortex determined using pharmaco‐magnetoencephalography , 2009, Human brain mapping.

[5]  J. Pérez-Castrillón,et al.  Roxithromycin-Induced Eosinophilic Pneumonia , 2002, The Annals of pharmacotherapy.

[6]  T. Yamamoto,et al.  Deep brain stimulation therapy for a persistent vegetative state. , 2002, Acta neurochirurgica. Supplement.

[7]  P. Bartolomeo,et al.  Zolpidem in Parkinson's disease , 1997, The Lancet.

[8]  M Tombini,et al.  Long‐term effects of stroke on neuronal rest activity in rolandic cortical areas , 2006, Journal of neuroscience research.

[9]  A. Jonville-Béra,et al.  Beneficial Effect of Zolpidem for Dementia , 2002, The Annals of pharmacotherapy.

[10]  Krish D. Singh,et al.  A new approach to neuroimaging with magnetoencephalography , 2005, Human brain mapping.

[11]  Gareth R. Barnes,et al.  The missing link: analogous human and primate cortical gamma oscillations , 2005, NeuroImage.

[12]  J. Lewine,et al.  Magnetoencephalographic assessment of spontaneous brain activity in schizophrenia. , 1996, Psychopharmacology bulletin.

[13]  J. Vrba,et al.  Signal processing in magnetoencephalography. , 2001, Methods.

[14]  R. Riggs,et al.  Positive outcomes in traumatic brain injury-vegetative state: patients treated with bromocriptine. , 2001, Archives of physical medicine and rehabilitation.

[15]  J. Poza,et al.  Analysis of Spontaneous MEG Activity in Patients with Alzheimer's Disease using Spectral Entropies , 2007, 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[16]  B. Axelrod,et al.  Practice Effects on the WAIS-III Across 3- and 6-Month Intervals , 2002, The Clinical neuropsychologist.

[17]  R. Clauss,et al.  Drug induced arousal from the permanent vegetative state. , 2006, NeuroRehabilitation.

[18]  M. Nuwer,et al.  Routine and quantitative EEG in mild traumatic brain injury , 2005, Clinical Neurophysiology.

[19]  P. Brown,et al.  Reduction in subthalamic 8–35 Hz oscillatory activity correlates with clinical improvement in Parkinson's disease , 2006, The European journal of neuroscience.

[20]  G. Pfurtscheller,et al.  Functional brain imaging based on ERD/ERS , 2001, Vision Research.

[21]  Mujeeb Khan,et al.  Zolpidem for Antipsychotic-Induced Parkinsonism , 2001, The Annals of pharmacotherapy.

[22]  Adrian L. Williams,et al.  Task-Related Changes in Cortical Synchronization Are Spatially Coincident with the Hemodynamic Response , 2002, NeuroImage.

[23]  A. Thomson,et al.  Differential sensitivity to Zolpidem of IPSPs activated by morphologically identified CA1 interneurons in slices of rat hippocampus , 2000, The European journal of neuroscience.

[24]  K. Goa,et al.  Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia. , 2000, Drugs.

[25]  L. Cohen,et al.  Transient improvement of aphasia with zolpidem. , 2004, The New England journal of medicine.

[26]  R. Clauss,et al.  Effect of Zolpidem on Brain Injury and Diaschisis as Detected by 99mTc HMPAO Brain SPECT in Humans , 2004, Arzneimittelforschung.

[27]  Mikko Pohja,et al.  On the human sensorimotor-cortex beta rhythm: Sources and modeling , 2005, NeuroImage.

[28]  G. Plosker,et al.  Zaleplon: a review of its use in the treatment of insomnia. , 2000, Drugs.

[29]  K. D. Singh,et al.  Co-registration of magnetoencephalography with magnetic resonance imaging using bite-bar-based fiducials and surface-matching , 2004, Clinical Neurophysiology.

[30]  H. Ring,et al.  Transient reversal of anoxic brain injury-related minimally conscious state after zolpidem administration: a case report. , 2008, Archives of physical medicine and rehabilitation.